Menu Search
Equities

DaVita Inc

DVA:NYQ

DaVita Inc

Actions
Health CareHealth Care Providers
  • Price (USD)149.66
  • Today's Change-0.71 / -0.47%
  • Shares traded748.66k
  • 1 Year change+76.47%
  • Beta0.8657
Data delayed at least 15 minutes, as of Nov 09 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year DaVita Inc grew revenues 4.57% from 11.61bn to 12.14bn while net income improved 23.40% from 560.40m to 691.54m.
Gross margin32.80%
Net profit margin8.94%
Operating margin14.96%
Return on assets6.58%
Return on equity104.38%
Return on investment8.88%
More ▼

Cash flow in USDView more

In 2023, DaVita Inc increased its cash reserves by 37.06%, or 125.65m. The company earned 2.06bn from its operations for a Cash Flow Margin of 16.96%. In addition the company used 771.80m on investing activities and also paid 1.17bn in financing cash flows.
Cash flow per share20.97
Price/Cash flow per share6.54
Book value per share4.68
Tangible book value per share-85.19
More ▼

Balance sheet in USDView more

DaVita Inc has a Debt to Total Capital ratio of 81.15%, a lower figure than the previous year's 690.89%.
Current ratio1.37
Quick ratio1.33
Total debt/total equity24.71
Total debt/total capital0.8115
More ▼

Growth rates in USD

Year on year, growth in earnings per share excluding extraordinary items increased 30.03%. Additionally, five year annualized earnings per share growth is in-line with the industry average relative to its peers.
EPS growth(5 years)15.72
EPS (TTM) vs
TTM 1 year ago		45.41
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.